Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06561581

Acuity Functional Impact and Implementation Outcomes Evaluation

This study will test feature enhancements to a behavioral therapy data collection software (Motivity) that will add a new clinical decision support module, called Acuity. Acuity is a Quality Improvement (QI) intervention targeted at Behavior Analysts (BAs) and Behavior Technicians (BTs) that aims to improve the delivery of autism behavioral therapy. Subjects will be staff recruited from existing Motivity customers.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Autism Autism Spectrum Disorder Autistic Disorder Child Development Disorders, Pervasive Mental Disorders Neurodevelopmental Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Experiad LLC

Honolulu, Hawaii, 96816, United States

About this study

Acuity is intended to provide significant improvements in treatment planning, progress tracking, trend monitoring, and dosage management. If successful, Acuity will provide Applied Behavior Analysis (ABA) practitioners with a higher level of real-time insight into their clinical data, enabling more efficient and productive treatment. Research has shown that first-generation systems fall short in supporting overworked BAs who are overwhelmed with data. Acuity will address critical shortfalls by enabling more agile corrective actions and data-driven planning across multiple aspects of treatment, providing practitioners with new levels of rigorous, real-time insight into their clinical data. Acuity will help BAs establish and adhere to realistic treatment timelines, and will proactively alert the BA to noteworthy trends in the data as they occur, such as learner performance issues, missed dosages, and significant changes in tracked behaviors. In doing so, Acuity will support more responsive and effective treatment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Behavior Analysts and Behavior Technicians treating kids with autism
  • Must be employed by one of the autism treatment clinics that have agreed to participate in the study.
  • Must be employed by Experiad customers who are using Motivity software as part of their practice.

Exclusion criteria

  • All people not listed above

Treatment and study plan

Acuity

Behavioral

Enhancement to Motivity product for clinical decision support

Other names: Motivity

Primary outcomes

  1. Number of participants with improved estimation of Trials to Criterion and Time (days) to Criterion

    Time frame: through study completion, expected to be 18 months from the start of retroactive observation period

    Does Acuity make initial timeline estimates for sets of targets more accurate?

  2. Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion.

    Time frame: through study completion, expected to be 18 months from the start of retroactive observation period

    Does Acuity result in corrective action being taken more quickly for programs that are off schedule or targets that are exhibiting performance issues?

  3. Increased adherence to prescribed dosage

    Time frame: through study completion, expected to be 18 months from the start of retroactive observation period

    Does Acuity result in increased adherence to prescribed dosage, as measured by system

  4. Number of participants who find Acuity and its components practical and possible to use, assessed by qualitative measures and system usage tracking

    Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period

    Feasibility - To what extent are Acuity and its components practical or possible to use?

  5. Proportion of clinics and providers that actively use Acuity, assessed by system usage tracking.

    Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period

    Adoption - What proportion of clinics and providers are willing to use Acuity and how well do they represent the population of clinics and providers?

  6. Number of BAs & BTs who utilize Acuity as intended to provide learners with accurate treatment plans, and achieve expected results, as measured by system usage and qualitative assessment.

    Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period

    Fidelity - the degree to which BAs and BTs use the system as expected, including dosage adherence, treatment planning accuracy, and timely protocol modification.

  7. Majority of BAs and BTs rate Acuity and its components as attractive, agreeable, or palatable.

    Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period

    Acceptability, as measured by SUS score and SUS Items 1, 5, 6 & 8 collected via online survey at the end of O0 & O1 from both arms.

  8. Frequency at which Acuity and its components are rated as suitable, fitting, or proper for achieving the goals set forth in treatment plans, as measured by surveys.

    Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period

    Appropriateness - Same measures captured for all primary & secondary research questions in the Functional Impact Evaluation. Brief online survey with Likert scaled items focused on the providers' assessment of how well Acuity and its components are matched to the challenges of planning and executing Treatment Plans.

Sponsors and collaborators

Lead sponsor

Experiad LLC

Industry

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Aug 20, 2024
Registry last updated
Aug 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.